We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 1

Figure 1. From: The Prevalence of Macular Telangiectasia Type 2 (MT2) in the Beaver Dam Eye Study.

Lesions characterizing macular telangiectasia type 2 from patients not participating in the Beaver Dam Eye Study. A. Loss of transparency; B. Retinal crystals (black arrow) and pigment clumping (white arrow); C. Lamellar hole (black arrow), yellowish spot, and retinal vessel blunting (white arrow); D. Telangiectatic retinal vessels (black arrow), pigment clumping, and RPE depigmentation.

Ronald Klein, et al. Am J Ophthalmol. ;150(1):55-62.e2.
2.
Figure 2

Figure 2. From: The Prevalence of Macular Telangiectasia Type 2 (MT2) in the Beaver Dam Eye Study.

Development of macular telangiectasia type 2 in right eye of participant categorized as having macular telangiectasia type 2 in left eye. L. Baseline - left eye with blunted retinal vessels, retinal pigment clumping, retinal crystalline deposits, RPE depigmentation, and retinal telangiectatic vessels (black arrow); 5 year follow-up visit - a temporal lesion of pigment clumping and depigmentation has appeared with increasing size at the 10 year and 15 year follow-up visits (white arrow); R. Baseline and 5 year follow-up visit - right eye with beginnings of blunted retinal vessels and retinal crystals; 10 year follow-up visit - now labeled as having macular telangiectasia type 2 with retinal crystals, pigment clumping, and RPE depigmentation temporal to the macula (black arrow); 15 year follow-up visit - a temporal lesion of retinal pigment clumping and depigmentation (white arrow) similar to the left eye has developed.

Ronald Klein, et al. Am J Ophthalmol. ;150(1):55-62.e2.
3.
Figure 3

Figure 3. From: The Prevalence of Macular Telangiectasia Type 2 (MT2) in the Beaver Dam Eye Study.

Four other participants with macular telangiectasia type 2 at the Beaver Dam Eye Study baseline examination in 1988–90. A. Right eye with pigment clumping (black arrow), retinal crystals, retinal vessel blunting, and RPE depigmentation; B. Left eye of same person with lamellar hole (green arrow), pigment clumping, RPE depigmentation, and retinal crystals; C. Left eye with RPE depigmentation (black/white arrow), pigment clumping, retinal crystals, and a loss of retinal transparency; other eye with no signs of macular telangiectasia type 2 is not shown; D. Left eye with retinal crystals (yellow arrow), pigment clumping, and RPE depigmentation; other eye with no signs of macular telangiectasia type 2 is not shown; E. Right eye with loss of retinal transparency (gray arrows), retinal vessel blunting, retinal crystals, pigment clumping and RPE depigmentation; F. Left eye of same person with a lamellar hole, loss of retinal transparency, vessel blunting, retinal crystals, pigment clumping and RPE depigmentation.

Ronald Klein, et al. Am J Ophthalmol. ;150(1):55-62.e2.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk